apnea – COOPER GENERAL NEWS

But many patients find sleeping with a face mask less awkward or uncomfortable than using a CPAP machine. The technical term for these devices is mandibular advancement device, so named because it pushes the mandible forward, which in most people helps keep the airway open. There are many variations of these devices in drug stores, but a dentist can design a more effective personalized device and modify or customize it if necessary. The patients in the laryngoscope study were all reexamined after the initial adjustment and most adjustments needed over a period of two to four weeks.

“We recommend a custom device made by a dentist,” said Dr. Benjamin. “And you should be retested to see how well it works. There are subjective and objective improvements that should be pursued. “

But there are people for whom neither CPAP nor dental devices work, either because they cannot use them consistently and correctly, or because the devices themselves do not solve the problem if they are used correctly. Various effective surgical procedures exist for these patients.

The most common is soft tissue surgery, which involves modifying or removing tissue from the back of the mouth. Depending on the structures and muscles of the mouth, the surgeon can trim the soft palate and uvula, remove the tonsils, shrink tissue with a heated instrument, straighten a crooked septum or change the position of the tongue muscles – all with the aim of improving airflow.

There are also bone surgeries that move the jaw forward to increase the total breathing space, a procedure that can involve a lengthy recovery period.

In 2014, the Food and Drug Administration approved a device called the Inspire Upper Airway Stimulation. This is a small device that is implanted under the skin like a pacemaker. Using two electrical wires, it detects the breathing pattern and stimulates the nerve that controls the tongue to move it out of the way and allow the air to flow freely. Implantation is a daily surgical procedure that takes about two hours.

“It doesn’t change the anatomy, and recovery is easier than with other surgeries,” said Dr. Maria V. Suurna, Associate Professor of Otorhinolaryngology at Weill Cornell Medicine, who specializes in sleep apnea surgery. “It’s effective. It has the lowest complication rate of any surgery.

The U.S. Food and Drug Administration on Friday approved a new device that can help prevent sleep apnea and snoring – and that doesn’t have to be worn at night.

People who snore – and their partners – have very few options in the market right now to alleviate their suffering. And a lot of what is available involves uncomfortable mouthguards or noisy C-Pap machines.

Approved on Friday, the eXciteOSA device is the first of its kind to be approved to treat sleep apnea and snoring by improving tongue muscle function by electrically stimulating the tongue through a mouthpiece worn for 20 minutes a day. It helps retrain the tongue to prevent it from collapsing backwards and blocking airflow while you sleep.

Obstructive sleep apnea is widespread and occurs when the upper airway becomes repeatedly blocked during sleep, reducing or completely blocking airflow. If left untreated, OSA can lead to serious complications such as glaucoma, heart attack, diabetes, cancer, and cognitive and behavioral disorders.

“Obstructive sleep apnea not only affects the quality of sleep, it can also have other serious health effects if left untreated. Today’s approval provides a new option for thousands of people with snoring or mild sleep apnea,” said Dr. Malvina Eydelman, director of the Ophthalmic, Anesthetic, Respiratory, ENT, and Dental Devices Bureau at the FDA’s Center for Equipment and Radiological Health.

The eXciteOSA mouthpiece has four electrodes, two above the tongue and two under the tongue. It provides electrical muscle stimulation in sessions that consist of a series of electrical impulses with periods of rest in between. It is used once a day for 20 minutes while you are awake, for 6 weeks, and then once a week thereafter.

The agency said the device reduced loud snoring by 20% in 87 of the 115 patients studied. Of the patients who all snored, 48 also had mild sleep apnea.

The most common side effects observed were excessive salivation, tongue or tooth discomfort, tongue tingling, tenderness to filling, metallic taste, gagging, and tight jaw.

The FDA has granted Signifier Medical Technologies marketing authorization.